亿腾上市新路径:与嘉和生物合并引领行业变革

极目新闻
23 Oct 2024

近日,港股市场风云再起,生物医药板块迎来了一场备受关注的合并盛事。国庆假期归来,嘉和生物-B在停牌近一月后重新亮相,此次携手,不仅有助于嘉和生物加速转型,更为亿腾上市带来了新的契机。10月7日,嘉和生物正式对外公告,宣布将以换股的方式与亿腾医药合并,合并后的新实体或将命名为亿腾嘉和。在这场合并中,亿腾医药股东将持有新公司77.43%的股权,成为绝对的控股股东,而嘉和生物股东则持有剩余的22.57%...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10